Diagnostic issues in a family with late onset type 2 neurofibromatosis.
We report a family with type 2 neurofibromatosis and late onset tumours. Five members of this family have developed hearing loss late in life, two of whom have only been shown to have the diagnosis in their seventies, and three other obligate gene carriers died undiagnosed at 64, 72, and 78 years of age. A missense mutation at the C-terminal end of the NF2 protein has been identified in this family and segregates with disease. The use of highly polymorphic markers for predictive testing is also shown. There appears to be an autosomal dominant form of spinocerebellar degeneration which is segregating separately to NF2 in this family, which created a diagnostic dilemma.
Evans
D G
DG
Department of Medical Genetics, St Mary's Hospital, Manchester, UK.
Bourn
D
D
Wallace
A
A
Ramsden
R T
RT
Mitchell
J D
JD
Strachan
T
T
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001483:Base Sequence; D002648:Child; D004247:DNA / Q000032:analysis; D005260:Female; D006239:Haplotypes; D006801:Humans; D008297:Male; D008565:Membrane Proteins / Q000235:genetics*; D008875:Middle Aged; D008969:Molecular Sequence Data; D009154:Mutation; D016518:Neurofibromatosis 2 / Q000175:diagnosis* / Q000235:genetics; D025581:Neurofibromin 2; D010375:Pedigree; D016133:Polymerase Chain Reaction; D018807:Polymorphism, Single-Stranded Conformational; D013132:Spinocerebellar Degenerations / Q000235:genetics
D008565:Membrane Proteins; D025581:Neurofibromin 2; D004247:DNA